POSA53 The Cost-Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease and Heart Failure in the UK

Abstract

Authors

T Ward G Baxter A Ramirez de Arellano Serna

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×